Dimethylformamide → HCID 66576289, compound
Reaction equation
[CH3:1][N:2]1[C:6]([CH3:7])=[CH:5][C:4]([C:8]2[O:12][N:11]=[C:10]([C:13]([OH:15])=O)[N:9]=2)=[N:3]1.[NH2:16][C@@H:17]([CH3:34])[CH2:18][N:19]1[CH:23]=[CH:22][C:21]([C:24]2[CH:31]=[C:30]([F:32])[C:27]([C:28]#[N:29])=[C:26]([Cl:33])[CH:25]=2)=[N:20]1.CN(C=O)C>O.CCOC(C)=O>[Cl:33][C:26]1[CH:25]=[C:24]([C:21]2[CH:22]=[CH:23][N:19]([CH2:18][C@@H:17]([NH:16][C:13]([C:10]3[N:9]=[C:8]([C:4]4[CH:5]=[C:6]([CH3:7])[N:2]([CH3:1])[N:3]=4)[O:12][N:11]=3)=[O:15])[CH3:34])[N:20]=2)[CH:31]=[C:30]([F:32])[C:27]=1[C:28]#[N:29]Participants
Procedure
The title compound was prepared using the procedure described in Example 3(h) starting from 5-(1,5-dimethyl-1H-pyrazol-3-yl)-1,2,4-oxadiazole-3-carboxylic acid (1.614 mmol, 0.336 g) and (S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2-chloro-6-fluoro-benzonitrile (1.345 mmol, 0.375 g) using DMF (10 ml) as the solvent. The reaction mixture was diluted with water and EtOAc, the phases were separated and the organic phase was washed with 2 M Na2CO3, water and brine. The organic phase was dried, filtered and evaporated. The crude product was purified by flash chromatography and preparative HPLC, respectively. 0.003 g of the title compound was obtained. 1H-NMR (400 MHz, CDCl3): δ 1.29 (d, 3H), 2.34 (s, 3H), 4.24 (s, 3H), 4.30 (dd, 1H), 4.49 (dd, 1H), 4.61-4.72 (m, 1H), 6.65 (d, 1H), 6.88 (s, 1H), 7.53 (d, 1H), 7.61 (dd, 1H), 7.78-7.82 (m, 1H), 8.01 (d, 1H).
Workup
- customThe title compound was prepared
- customthe phases were separated
- washthe organic phase was washed with 2 M Na2CO3, water and brine
- customThe organic phase was dried
- filtrationfiltered
- customevaporated
- customThe crude product was purified by flash chromatography and preparative HPLC
Sources & evidence
- ORD record
- ord-4377d626682e458696f28c2c91e38c7d
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08921378B2
Reaction notes
Loading…